These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 18725808)

  • 1. Emergence of resistance mutations preceding virologic failure in patients receiving antiretroviral therapy.
    Diaz RS; Accetturi CA; Sucupira MC
    J Acquir Immune Defic Syndr; 2008 Sep; 49(1):111-3. PubMed ID: 18725808
    [No Abstract]   [Full Text] [Related]  

  • 2. Virologic suppression in response to antiretroviral therapy despite extensive resistance within HIV-1 reverse transcriptase after the first virologic failure.
    Oliveira MI; Romão de Souza Junior V; Fernanda de Lacerda Vidal C; Sérgio Ramos de Araújo P
    BMC Infect Dis; 2018 Oct; 18(1):514. PubMed ID: 30314470
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rate of virologic failure and selection of drug resistance mutations using different triple nucleos(t)ide analogue combinations in HIV-infected patients.
    Martín-Carbonero L; Gil P; García-Benayas T; Barreiro P; Blanco F; de Mendoza C; Maida I; González-Lahoz J; Soriano V
    AIDS Res Hum Retroviruses; 2006 Dec; 22(12):1231-5. PubMed ID: 17209764
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Resistance to antiretroviral therapy.
    Deshpande A
    J Assoc Physicians India; 2012 Dec; 60():9. PubMed ID: 23781663
    [No Abstract]   [Full Text] [Related]  

  • 5. Can drug resistance mutations influence the measurement of plasma HIV-RNA by different viral load techniques?
    Poveda E; de Mendoza C; Cuesta M; Toro C; Rodés B; Soriano V
    AIDS Patient Care STDS; 2003 Jul; 17(7):321-4. PubMed ID: 12952733
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Study of the impact of HIV genotypic drug resistance testing on therapy efficacy.
    Van Vaerenbergh K
    Verh K Acad Geneeskd Belg; 2001; 63(5):447-73. PubMed ID: 11813503
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effectiveness of first-line antiretroviral therapy and acquired drug resistance among HIV-1-infected children in India.
    Shet A; Neogi U; Sahoo PN; De Costa A
    Pediatr Infect Dis J; 2013 May; 32(5):e227-9. PubMed ID: 23249907
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Virologic failure among children taking lopinavir/ritonavir-containing first-line antiretroviral therapy in South Africa.
    Meyers T; Sawry S; Wong JY; Moultrie H; Pinillos F; Fairlie L; van Zyl G
    Pediatr Infect Dis J; 2015 Feb; 34(2):175-9. PubMed ID: 25741970
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Mutations resulting in resistence of antiretroviral drugs in HIV-infected patients].
    Cabrera C; Clotet B
    Med Clin (Barc); 2005 Apr; 124(16):618-9. PubMed ID: 15871779
    [No Abstract]   [Full Text] [Related]  

  • 10. HIV-1 drug resistance evolution among patients on potent combination antiretroviral therapy with detectable viremia.
    Napravnik S; Edwards D; Stewart P; Stalzer B; Matteson E; Eron JJ
    J Acquir Immune Defic Syndr; 2005 Sep; 40(1):34-40. PubMed ID: 16123679
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of antiretroviral drug resistance.
    Wainberg MA; Zaharatos GJ; Brenner BG
    N Engl J Med; 2011 Aug; 365(7):637-46. PubMed ID: 21848464
    [No Abstract]   [Full Text] [Related]  

  • 12. Research on the treatment effects and drug resistances of long-term second-line antiretroviral therapy among HIV-infected patients from Henan Province in China.
    Chen J; Zhang M; Shang M; Yang W; Wang Z; Shang H
    BMC Infect Dis; 2018 Nov; 18(1):571. PubMed ID: 30442114
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prospective long-term outcomes of a cohort of Ugandan children with laboratory monitoring during antiretroviral therapy.
    Kekitiinwa A; Asiimwe AR; Kasirye P; Korutaro V; Kitaka S; Maganda A; Madalon M; Graziano FM
    Pediatr Infect Dis J; 2012 Aug; 31(8):e117-25. PubMed ID: 22581223
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High Prevalence of Drug Resistance Mutations Among Patients Failing First-Line Antiretroviral Therapy and Predictors of Virological Response 24 Weeks After Switch to Second-Line Therapy in São Paulo State, Brazil.
    Matsuda EM; Coelho LPO; Romero GF; de Moraes MJ; Lopez-Lopes GIS; Morejon K; Campeas AE; Cabral GB; Brígido LFM
    AIDS Res Hum Retroviruses; 2018 Feb; 34(2):156-164. PubMed ID: 28969448
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High rates of baseline antiretroviral resistance among HIV-infected pregnant women in an HIV referral centre in Rio de Janeiro, Brazil.
    de Lourdes Teixeira M; Nafea S; Yeganeh N; Santos E; Gouvea MI; Joao E; Ceci L; Bressan C; Cruz ML; Sidi LC; Nielsen-Saines K
    Int J STD AIDS; 2015 Nov; 26(13):922-8. PubMed ID: 25504831
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Short communication: east meets west: a description of HIV-1 drug resistance mutation patterns of patients failing first line therapy in PEPFAR clinics from Uganda and Nigeria.
    Crawford KW; Wakabi S; Kibuuka H; Magala F; Keshinro B; Okoye I; Akintunde E; Hamm TE
    AIDS Res Hum Retroviruses; 2014 Aug; 30(8):796-9. PubMed ID: 24798614
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Management of Virologic Failure and HIV Drug Resistance.
    McCluskey SM; Siedner MJ; Marconi VC
    Infect Dis Clin North Am; 2019 Sep; 33(3):707-742. PubMed ID: 31255384
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Viro-immunological response and emergence of resistance in HIV-infected women receiving combination antiretroviral regimens for the prevention of mother-to-child transmission in Malawi.
    Palombi L; Galluzzo CM; Pirillo MF; Liotta G; Andreotti M; Jere H; Sagno JB; Luhanga R; Mancinelli S; Ceffa S; Amici R; Marazzi MC; Vella S; Giuliano M
    J Antimicrob Chemother; 2014 Mar; 69(3):749-52. PubMed ID: 24135952
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High prevalence of antiretroviral drug resistance mutations in HIV-1 non-B subtype strains from African children receiving antiretroviral therapy regimen according to the 2006 revised WHO recommendations.
    Gody JC; Charpentier C; Mbitikon O; Si-Mohamed A; LeGoff J; Grésenguet G; Bélec L
    J Acquir Immune Defic Syndr; 2008 Dec; 49(5):566-9. PubMed ID: 19202461
    [No Abstract]   [Full Text] [Related]  

  • 20. Replication capacity, biological phenotype, and drug resistance of HIV strains isolated from patients failing antiretroviral therapy.
    Nicastri E; Sarmati L; d'Ettorre G; Palmisano L; Parisi SG; Uccella I; Rianda A; Concia E; Vullo V; Vella S; Andreoni M
    J Med Virol; 2003 Jan; 69(1):1-6. PubMed ID: 12436471
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.